Secukinumab is Superior to Ustekinumab in Clearing Skin of Patients with Moderate to Severe Plaque Psoriasis: CLARITY, a Randomized, Controlled, Phase 3b Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S27, 2018. Disponível em: https://skin.dermsquared.com/skin/article/view/261. Acesso em: 18 may. 2025.